3Mavragani CP, Moutsopoulos HM. Rheumatoid arthritis in the elderly [ J ]. Exp Gerontol, 1999,34 (3) : 463-471.
4Deal CL, Meean RF, Goldenberg DL, et al. The clinical features of elderlyonset rheumatoid arthritis. A comparison with younger-onset disease of similar duration [ J ]. Arthritis Rheum, 1985,28(9) :987-994.
5Terkeltaub R, Esdaile J, Decary F, et al. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group [ J ]. J Rheumatol, 1983,10 ( 3 ) :418-424.
6Ferraccioli GF, Cavalieri F, Mercadanti M, et al. Clinical features, scintiscan characteristics and X-ray pro- gression of late onset rheumatoid arthritis [ J ]. Clin Exp Rheumatol, 1984,2(2) : 157-161.
7Ceccato F, Roverano S, Barrionuevo A, et al. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica [ J ]. Clin Rheumatol, 2006,25 (6) :854-857.
8Hetland ML, Stengaard-Pedersen K, Junker P,et al. Aggressive combination therapy with intraarticular glucocorticoid injections and conventional DMARDs in early rheumatoid arthritis Two Year Clinical and Radiographic Results From the CIMESTRA Study [ J ]. Ann Rheum Dis, 2007, Sep 18, [ Epub ahead of print].
9ACR Subcommittee on rheumatoid arthritis guidelines. Guidelines for the management of rheumatoid arthritis [ J ]. Arthritis Rheum, 2002,46 ( 2 ) : 328-346.
10Emery P. Evidence supporting the benefit of early intervention in rheumatoid arthritis [ J ]. J Rbeumatol Suppl.2002 ,66 :3-8.
二级参考文献12
1O'Dell JR. Left R, Paulsen G, et al. Trealment of rheumatoid arthritis with methotrexate and hydmxyehloroqulne, methotrexate and sulfasalazine, or a combination of the three medications: results of a two - year. randomized, double - blind, placebo - controlled trial. Arthritis Rheum, 2002, 46(5): 1164 - 1170.
2Kremer JM. Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arlhritis despite stable doses of merhotrexate. A randomized, double- blind,placebo - controlled trial. Ann Intern Med, 2002, 137(9): 726 -733.
3Totokawa S. Furuya T, Nakajima A, et al. Effects of low dose methotrexate Iherapy in rheumaloid arthritis: a comparison of three different dosage regimens. Ryumachi, 1997, 37 (5): 681 -687.
4Glennas A, Kvien TK, Andrup O, et al. Auranofin is safe and superior to placebo in elderly - onset rheumatoid arthritis. Br J Rheum, 1997, 36:870 - 877.
5Favalli EG, Sinigaglia L, Varenna M, et al. Drug- induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus,2002, 11 ( 11 ) :753 - 755.
6Brown SL, Greene MH, Gershon SK. et al. Tumor necrosis factor antagonist therapy and lymphnma development: twenty- six cases reported to the Food and Drug administration. Arthritis Rheum, 2002,46( 12): 3151 - 3158.
7Lockie LM, Gomez E, Smith DM.Low dose adrenocorticosteroids in the management of elderly patients and summary of efficacy in the long-term treatment of 97 patients .Semin Arthritis Rheum,1983,12(4):373 - 381.
8Conn DL,Lim SS. New role for an old friend: prednisone is a disease- modifying agent in early RA. Curr Opin Rheumatol, 2003,15(3): 2193 -2196.
9ACR Subcommittee on rheumatoid arthrilis guidelines, Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 2002, 46(2): 328 - 346.
10Emery P. Evidence supporting the benefit of early intervention in rheumatoid arthritis .J Rheumatol Suppl , 2002, 66:3 - 8.
